An increase in CD62L


Journal

Scandinavian journal of immunology
ISSN: 1365-3083
Titre abrégé: Scand J Immunol
Pays: England
ID NLM: 0323767

Informations de publication

Date de publication:
Jun 2021
Historique:
revised: 06 12 2020
received: 25 09 2020
accepted: 17 01 2021
pubmed: 23 1 2021
medline: 2 6 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

A high incidence of pulmonary embolism (PE) is reported in patients with critical coronavirus disease 2019 (COVID-19). Neutrophils may contribute to this through a process referred to as immunothrombosis. The aim of this study was to investigate the occurrence of neutrophil subpopulations in blood preceding the development of COVID-19 associated PE. We studied COVID-19 patients admitted to the ICU of our tertiary hospital between 19-03-2020 and 17-05-2020. Point-of-care fully automated flow cytometry was performed prior to ICU admission, measuring the neutrophil activation/maturation markers CD10, CD11b, CD16 and CD62L. Neutrophil receptor expression was compared between patients who did or did not develop PE (as diagnosed on CT angiography) during or after their ICU stay. Among 25 eligible ICU patients, 22 subjects were included for analysis, of whom nine developed PE. The median (IQR) time between neutrophil phenotyping and PE occurrence was 9 (7-12) days. A significant increase in the immune-suppressive neutrophil phenotype CD16 The increase in this neutrophil phenotype indicates that the increased number of CD16

Identifiants

pubmed: 33482019
doi: 10.1111/sji.13023
pmc: PMC7995011
doi:

Substances chimiques

Biomarkers 0
SELL protein, human 0
L-Selectin 126880-86-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13023

Subventions

Organisme : Netherlands Organisation for Scientific Research
ID : Startimpuls Dutch research Agenda

Investigateurs

Feike Stiphout (F)
Thomas M P Nijdam (TMP)
Nils L M van de Ven (NLM)
Remi Verhaegh (R)
Judith S Spanjaard (JS)
Benjamin W Verboeket (BW)
Duco Laane (D)
Karlijn van Wessem (K)
Daan E J van Spengler (DEJ)
Wiebe Buitenwerf (W)
Giulio Giustarini (G)
Eva Mulder (E)
Harry Heijerman (H)
Amely Daza Zabaleta (AD)
Frederique van den Bos (F)
Emma Rademaker (E)
Meri R J Varkila (MRJ)
Nikki de Mul (N)
Olaf L Cremer (OL)
Arjen Slooter (A)
Eveline M Delemarre (EM)
Stefan Nierkens (S)
Maarten Limper (M)
Femke van Wijk (F)
Aridaman Pandit (A)
Helen Leavis (H)
Chantal C Clark (CC)
Arjan D Barendrecht (AD)
Cor W Seinen (CW)
Sandra Drost-Verhoef (S)
Simone Smits (S)
Naomi M J Parr (NMJ)
Sylvie A E Sebastian (SAE)
Arnold C Koekman (AC)
Annet C van Wesel (AC)
Erhard van der Vries (E)
Coen Maas (C)
Steven de Maat (S)
Saskia Haitjema (S)
Imo E Hoefer (IE)

Informations de copyright

© 2021 The Authors. Scandinavian Journal of Immunology published by John Wiley & Sons Ltd on behalf of The Scandinavian Foundation for Immunology.

Références

Blood. 2020 Sep 3;136(10):1169-1179
pubmed: 32597954
Respiration. 2017;93(3):212-225
pubmed: 27997925
Scand J Immunol. 2021 Jun;93(6):e13023
pubmed: 33482019
Radiology. 2020 Sep;296(3):E189-E191
pubmed: 32324102
Kidney Int. 2020 Jul;98(1):219-227
pubmed: 32327202
Kidney Int. 2020 Jul;98(1):209-218
pubmed: 32416116
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32329756
J Clin Invest. 2012 Jan;122(1):327-36
pubmed: 22156198
Crit Care Explor. 2020 Jul 17;2(7):e0158
pubmed: 32766555
Immunity. 2017 Jan 17;46(1):15-28
pubmed: 28099862
J Thromb Haemost. 2010 Nov;8(11):2450-7
pubmed: 20738765
J Immunol Methods. 2019 Nov;474:112646
pubmed: 31419409
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
Lancet Rheumatol. 2020 Jul;2(7):e437-e445
pubmed: 32835247
Lancet Respir Med. 2020 Jul;8(7):738-742
pubmed: 32416769
Radiology. 2020 Sep;296(3):E186-E188
pubmed: 32324103
Thromb Res. 2018 Oct;170:87-96
pubmed: 30138777
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Crit Care. 2007;11(2):R31
pubmed: 17331245
Int J Cancer. 2017 Jun 1;140(11):2557-2567
pubmed: 28247912
Radiology. 2020 Dec;297(3):E335-E338
pubmed: 32407256
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083

Auteurs

Roy Spijkerman (R)

Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Nikita K N Jorritsma (NKN)

Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Suzanne H Bongers (SH)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Bas J J Bindels (BJJ)

Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Bernard N Jukema (BN)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Lillian Hesselink (L)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Falco Hietbrink (F)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Luke P H Leenen (LPH)

Department of Trauma Surgery, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Harriët M R van Goor (HMR)

Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Nienke Vrisekoop (N)

Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Karin A H Kaasjager (KAH)

Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Leo Koenderman (L)

Department of Respiratory Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH